Pine Bridge Investments, L.P. Supernus Pharmaceuticals, Inc. Transaction History

Pine Bridge Investments, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$14.45 - $24.69 $452,256 - $772,747	-31,298 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$19.93 - $29.13 $318,262 - $465,176	-15,969 Reduced 33.78%	31,298 $743,000
Q3 2019 Nov 13, 2019	BUY	$25.47 - $33.37 $104,095 - $136,383	4,087 Added 9.47%	47,267 $1.3 Million
Q2 2019 Aug 13, 2019	BUY	$29.96 - $38.87 $892,658 - $1.16 Million	29,795 Added 222.6%	43,180 $1.43 Million
Q1 2019 May 14, 2019	BUY	$32.77 - $41.99 $9,929 - $12,722	303 Added 2.32%	13,385 $469,000
Q4 2018 Feb 13, 2019	BUY	$30.84 - $49.51 $65,164 - $104,614	2,113 Added 19.26%	13,082 $434,000
Q3 2018 Nov 13, 2018	BUY	$42.7 - $56.55 $105,597 - $139,848	2,473 Added 29.11%	10,969 $552,000
Q2 2018 Aug 09, 2018	SELL	$44.1 - $59.85 $19,668 - $26,693	-446 Reduced 4.99%	8,496 $509,000
Q1 2018 May 14, 2018	SELL	$37.15 - $46.9 $380,824 - $480,771	-10,251 Reduced 53.41%	8,942 $410,000
Q4 2017 Feb 09, 2018	BUY	$36.4 - $42.6 $469,596 - $549,582	12,901 Added 205.04%	19,193 $765,000
Q3 2017 Nov 13, 2017	SELL	$36.75 - $49.65 $12,201 - $16,483	-332 Reduced 5.01%	6,292 $252,000
Q2 2017 Aug 11, 2017	BUY	N/A	6,624	6,624 $285,000

290

60.7M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.05B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Pine Bridge Investments, L.P. with notifications on news.